• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自适应成组序贯设计的精确推断

Exact inference for adaptive group sequential designs.

作者信息

Gao Ping, Liu Lingyun, Mehta Cyrus

机构信息

The Medicines Company, Parsippany, New Jersey 07054, USA.

出版信息

Stat Med. 2013 Oct 15;32(23):3991-4005. doi: 10.1002/sim.5847. Epub 2013 May 19.

DOI:10.1002/sim.5847
PMID:23686358
Abstract

Methods for controlling the type-1 error of an adaptive group sequential trial were developed in seminal papers by Cui, Hung, and Wang (Biometrics, 1999), Lehmacher and Wassmer (Biometrics, 1999), and Müller and Schäfer (Biometrics, 2001). However, corresponding solutions for the equally important and related problem of parameter estimation at the end of the adaptive trial have not been completely satisfactory. In this paper, a method is provided for computing a two-sided confidence interval having exact coverage, along with a point estimate that is median unbiased for the primary efficacy parameter in a two-arm adaptive group sequential design. The possible adaptations are not only confined to sample size alterations but also include data-dependent changes in the number and spacing of interim looks and changes in the error spending function. The procedure is based on mapping the final test statistic obtained in the modified trial into a corresponding backward image in the original trial. This is an advance on previously available methods, which either produced conservative coverage and no point estimates or provided exact coverage for one-sided intervals only.

摘要

崔、洪和王(《生物统计学》,1999年)、莱马赫和瓦斯默(《生物统计学》,1999年)以及米勒和舍费尔(《生物统计学》,2001年)在开创性论文中提出了控制适应性成组序贯试验I型错误的方法。然而,对于适应性试验结束时同样重要且相关的参数估计问题,相应的解决方案并不完全令人满意。本文提供了一种方法,用于计算具有精确覆盖率的双侧置信区间,以及在双臂适应性成组序贯设计中对主要疗效参数中位数无偏的点估计。可能的调整不仅限于样本量的改变,还包括中期观察次数和间隔的数据依赖变化以及误差消耗函数的变化。该程序基于将修改后的试验中获得的最终检验统计量映射到原始试验中的相应反向图像。这是对先前可用方法的改进,先前的方法要么产生保守的覆盖率且无点估计,要么仅为单侧区间提供精确覆盖率。

相似文献

1
Exact inference for adaptive group sequential designs.自适应成组序贯设计的精确推断
Stat Med. 2013 Oct 15;32(23):3991-4005. doi: 10.1002/sim.5847. Epub 2013 May 19.
2
Exact confidence bounds following adaptive group sequential tests.自适应成组序贯检验后的精确置信区间。
Biometrics. 2009 Jun;65(2):539-46. doi: 10.1111/j.1541-0420.2008.01101.x.
3
Repeated confidence intervals for adaptive group sequential trials.适应性成组序贯试验的重复置信区间
Stat Med. 2007 Dec 30;26(30):5422-33. doi: 10.1002/sim.3062.
4
Adaptive designs for noninferiority trials.非劣效性试验的适应性设计。
Biom J. 2013 May;55(3):310-21. doi: 10.1002/bimj.201200034. Epub 2013 Mar 13.
5
An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size.对具有预先指定样本量修改规则的适应性临床试验设计的推断程序的评估。
Biometrics. 2014 Sep;70(3):556-67. doi: 10.1111/biom.12168. Epub 2014 Apr 25.
6
Estimation of a parameter and its exact confidence interval following sequential sample size reestimation trials.序贯样本量重新估计试验后参数估计及其精确置信区间
Biometrics. 2004 Dec;60(4):910-8. doi: 10.1111/j.0006-341X.2004.00246.x.
7
A simulation-based comparison of estimation methods for adaptive and classical group sequential clinical trials.
Pharm Stat. 2022 May;21(3):599-611. doi: 10.1002/pst.2188. Epub 2021 Dec 26.
8
A practical comparison of group-sequential and adaptive designs.成组序贯设计与适应性设计的实际比较
J Biopharm Stat. 2005;15(4):719-38. doi: 10.1081/BIP-200062859.
9
Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (II): sample size re-estimation.两阶段分组序贯试验中同时检验主要和次要终点的自适应调整(II):样本量再估计。
Stat Med. 2012 Aug 30;31(19):2041-54. doi: 10.1002/sim.5377. Epub 2012 Jun 26.
10
On adaptive error spending approach for group sequential trials with random information levels.关于具有随机信息水平的成组序贯试验的自适应误差消耗方法。
J Biopharm Stat. 2012;22(4):687-99. doi: 10.1080/10543406.2012.678232.

引用本文的文献

1
Confidence Intervals for Adaptive Trial Designs I: A Methodological Review.适应性试验设计的置信区间I:方法学综述
Stat Med. 2025 Aug;44(18-19):e70174. doi: 10.1002/sim.70174.
2
Use of Seamless Study Designs in Oncology Clinical Development- A Survey Conducted by IDSWG Oncology Sub-team.无缝研究设计在肿瘤学临床开发中的应用——IDSWG 肿瘤学分组进行的一项调查。
Ther Innov Regul Sci. 2024 Sep;58(5):978-986. doi: 10.1007/s43441-024-00676-9. Epub 2024 Jun 22.
3
Recent innovations in adaptive trial designs: A review of design opportunities in translational research.
适应性试验设计的最新创新:转化研究中的设计机会综述。
J Clin Transl Sci. 2023 Apr 28;7(1):e125. doi: 10.1017/cts.2023.537. eCollection 2023.
4
Point estimation for adaptive trial designs I: A methodological review.自适应试验设计的点估计 I:方法学综述。
Stat Med. 2023 Jan 30;42(2):122-145. doi: 10.1002/sim.9605. Epub 2022 Nov 30.
5
ANALYSIS OF "LEARN-AS-YOU-GO" (LAGO) STUDIES.“边做边学”(LAGO)研究分析。
Ann Stat. 2021 Apr;49(2):793-819. doi: 10.1214/20-aos1978. Epub 2021 Apr 2.
6
The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.适应性设计 CONSORT 扩展(ACE)声明:一份带有解释和说明指南的清单,用于报告使用适应性设计的随机试验。
BMJ. 2020 Jun 17;369:m115. doi: 10.1136/bmj.m115.
7
The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.适应性设计 CONSORT 扩展(ACE)声明:一份带有解释和说明指南的清单,用于报告使用适应性设计的随机试验。
Trials. 2020 Jun 17;21(1):528. doi: 10.1186/s13063-020-04334-x.
8
Estimation of treatment effects following a sequential trial of multiple treatments.多种治疗方法序贯试验后的治疗效果评估。
Stat Med. 2020 May 20;39(11):1593-1609. doi: 10.1002/sim.8497. Epub 2020 Mar 23.
9
Adaptive multiarm multistage clinical trials.自适应多臂多阶段临床试验。
Stat Med. 2020 Apr 15;39(8):1084-1102. doi: 10.1002/sim.8464. Epub 2020 Feb 11.
10
Adaptive designs in clinical trials: why use them, and how to run and report them.临床试验中的适应性设计:为何使用它们,以及如何实施和报告它们。
BMC Med. 2018 Feb 28;16(1):29. doi: 10.1186/s12916-018-1017-7.